Article info
PDFSatellite symposium report
Biosimilar monoclonal antibodies: the next frontier. A summary report from a symposium held at EAHP 2012
- Correspondence to Theodor Dingermann, Institute of Pharmaceutical Biology, Goethe University, Biocenter, Max-von-Laue-Str. 9, D-60438 Frankfurt/Main, Germany; Dingermann{at}em.uni-frankfurt.de
Citation
Biosimilar monoclonal antibodies: the next frontier. A summary report from a symposium held at EAHP 2012
Publication history
- Received April 27, 2012
- Accepted April 27, 2012
- First published June 23, 2012.
Online issue publication
May 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions